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Abstract
We review and summarize seven molecular genetic studies of 17 psychophysiological endophenotypes that comprise this
special issue of Psychophysiology, address criticisms raised in accompanying Perspective and Commentary pieces, and
offer suggestions for future research. Endophenotypes are polygenic, and possibly influenced by rare genetic variants.
Because they are not simpler genetically than clinical phenotypes, they are unlikely to assist gene discovery for
psychiatric disorder. Once genetic variants for clinical phenotypes are identified, associated endophenotypes are likely to
provide valuable insights into the psychological and neural mechanisms important to disorder pathology. This special
issue provides a foundation for informed future steps in endophenotype genetics, including the formation of large sample
consortia capable of fleshing out the many genetic variants contributing to individual differences in psychophysiological
measures.
Descriptors: Endophenotype, Molecular genetics, Genome-wide association study, Sequencing association analysis
“. . . as we know, there are known knowns; there are things that we know
that we know. We also know there are known unknowns; that is to say we
know there are some things we do not know. But there are also unknown
unknowns, the ones we don’t know we don’t know.”
—Donald Rumsfeld on the nature of the evidence for weapons of mass
destruction in Iraq, February 12, 2002
This special issue represents an unprecedented attempt to lay bare
the genetic bases of 17 measures representing extensively studied
fundamental psychophysiological processes. The genetic bases of
these processes are of considerable interest because of their poten-
tial to serve as endophenotypes for psychiatric disorder. Although
previous work has examined the heritability of these measures and
produced a smattering of candidate gene findings related to many
of them, few published genome-wide studies of any putative
endophenotypes exist. Our aim was to provide a comprehensive,
multifaceted, uniformly applied approach to the molecular-genetic
investigation of a wide range of psychophysiological measures
varying in their psychological complexity, heritability, and status
as endophenotypes. For each endophenotype, we conducted
biometric heritability analyses using twin and family data,
molecular-genetic heritability analyses examining the degree to
which individuals with similar endophenotype characteristics
showed corresponding similarity in their genotypes, a genome-
wide association study (GWAS) of the strength of association of
common SNPs (single nucleotide polymorphisms) with the
endophenotype, a genome-wide study of the strength of association
between autosomal genes and each endophenotype, candidate SNP
and gene studies undertaken to corroborate hypothesized associa-
tions derived from previous findings reported in the literature,
association analysis based on rare genetic variants in the human
exome, and an association analysis using variants identified
through whole-genome sequencing.
Like Mr. Rumsfeld, who failed to find what he was looking for,
our search for specific genetic effects on endophenotypes came up
short. Nonetheless, our work supports the notion that such effects
exist. Here, we discuss the strengths of the studies described in this
special issue, the limitations noted by the distinguished group of
commentators, and some directions for future searches.
Strengths of the MTFS Endophenotype Genetic Analyses
Our approach has a number of strengths, which we enumerate here.
Large Sample Size
We created the largest single sample ever employed for the genetic
analysis of putative endophenotypes, using laboratory procedures
intended to achieve continuity in variable operationalization over a
two-decade time span.
Genetically Informative Sample
The sample consisted of parent and twin offspring (N ∼4,900) who
were part of the Minnesota Twin Family Study (MTFS). Our use of
nuclear twin families made possible the investigation of the
molecular-genetic basis of the endophenotypes in the same sample
from which the biometric heritability of each could be estimated.
There was very wide variation in the biometric estimates of
heritability, from very high to essentially zero, which provided
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important context to evaluate the molecular-genetic results for each
endophenotype individually and for the entire set considered
together.
Due to the nature of our twin-family sample, the fact that we
obtained few significant results cannot easily be dismissed as due
to poor measurement. Almost all of our measures showed strong
evidence of heritability as well as similarity within monozygotic
(MZ) twin pairs. To the extent that MZ twins are parallel forms of
the same person, high MZ twin similarity provides direct evidence
of measurement reliability.
Broad Approach to Endophenotype Evaluation
Our endophenotypes represent broadly the domain of psycho-
physiological measures that have been used to inform our
understanding of psychopathology. Some of the endophenotypes
we studied tap basic processes, like orienting and habituation
(electrodermal reactivity), autonomic and central nervous system
arousal (electrodermal activity and resting state electroencephalo-
gram [EEG] power), and eye blink startle. Others constitute more
complex measures related to information processing and emotion,
like oddball P3 amplitude, inhibitory control over a prepotent
response in the antisaccade task, and affectively modulated startle.
Although we do not argue that these measures provide a representa-
tive sampling of psychophysiological endophenotypes and we
acknowledge that there may exist some endophenotypes that are
genetically more informative, our results are more broadly appli-
cable than they would be if our conclusions were dependent on
results from a single selectively analyzed and reported variable.
Evaluation Using Both Atheoretical and
Hypothesis-Driven Approaches
We used both agnostic, discovery-based and candidate-gene
guided approaches. A unique feature of our work was the exami-
nation of both common and rare variants. We used p-value sig-
nificance thresholds that ranged from very conservative to
somewhat less so, depending on the nature of the analysis and the
number of statistical tests conducted. Should other investigators
wish to use a different p-value threshold, our results are reported
at a level of detail that allows them to use our tabled data in the
articles and online supporting information to do so. We expect the
publication and archiving of our findings to be of particular value
in years to come to other investigators examining the molecular-
genetic basis of these endophenotypes and related measures.
These scientists will be able to use our archived data to examine
the strength of association we found for our psychophysiological
measures to genetic variants they identify in their work. Finally,
our data is to be archived in government repositories like dbGaP
(database of Genotypes and Phenotypes), and made accessible to
qualified investigators who wish to apply different analytic
methods and strategies.
Known Unknowns: Key Findings
Figure 1 and Table 1 summarize results from various methods that
we used across the seven empirical articles to study our 17
endophenotypes. Figure 1 shows that biometric heritability esti-
mates derived from the family data and from the SNP-based
genome-wide complex trait analysis (GCTA)-family method,
which statistically controls shared environmental influences, gen-
erally match each other, and show considerable range. The EEG
measures show especially high heritability, with several estimates
exceeding 80%. Most of the other endophenotypes, plus one of
the EEG measures (delta power), show moderate heritability,
falling in the 40–60% range. Affective modulated startle, by con-
trast and unlike overall startle, shows little evidence of heritability.
The GCTA values derived from unrelated individuals (GCTA-
Median in the figure) that provide an estimate of SNP heritability
fall considerably below the other two estimates for EEG, electro-
dermal, and P3 measures. This pattern, consistent with what is
called “missing heritability” in the literature, is often seen with
other phenotypes, and is interpreted to indicate that rare variants
and genetic mechanisms besides additive polygenicity are contrib-
uting to heritability. For antisaccade eye tracking error and overall
startle amplitude, there is little evidence of missing heritability.
While this could indicate that the genetic architecture of these
endophenotypes is different from the others, the standard errors of
these GCTA estimates across measures are large and overlapping,
indicating that replication is desired to rule out the possibility that
chance fluctuations based on sample characteristics account for
the SNP heritability differences across endophenotypes. The SNP
heritability of the two modulated startle measures is essentially
zero, supporting the conclusion that startle difference scores are
not heritable and likely poor endophenotype candidates despite
the substantial literature linking them to several psychiatric
disorders.
Table 1 provides a summary of molecular-genetic findings.
What is striking is that most (89%) of the 153 cells are empty. The
discovery-based analyses involving genome-wide testing of the
approximately 527,000 SNPs, 17,000 genes, 85,000 exome chip
rare variants, and 27 million sequenced variants produced only a
few findings. By current convention, none can be considered valid
discoveries in the absence of replication. Although one advantage
of the discovery-based approach is the opportunity to capitalize on
novel etiological insights that might arise from unexpected effects
(see how Ford in this issue interpreted the delta power DEFA4/
DEFA6 finding in light of the hypothesized role of inflammation to
the pathophysiology of schizophrenia), unreplicated “discoveries”
appear more plausible if they can be linked to the endophenotype
through a known biological mechanism. Of the 11 genes in Table 1
identified through genome-wide studies, four appear likely to affect
brain function. MYEF2, myelin expression factor 2, stands out
because of the importance of myelin sheathing to nerve conduc-
tion. PARD3, PNPLA7, and GBX2 concern brain function. The
latter three represent tentative discoveries based on rare variants,
and all are in need of replication.
Findings for candidate SNP and gene analyses were even
scanter, especially given the relaxed p-value thresholds relative to
those adopted for the genome- and exome-wide tests. We examined
1,180 endophenotype-general candidate SNPs selected as likely to
be relevant to psychiatric disorders related to the endophenotypes
based on the best leads available in the literature. We also examined
SNPs reported in the literature based on their prior association with
a specific endophenotype. None of these SNP analyses produced a
significant result.
Three sets of candidate gene analyses were also undertaken:
204 endophenotype-general candidate genes selected from the
neuroSNP data base (Saccone et al., 2009) because they are
involved in neural systems or substance-metabolizing pathways
that might reasonably be expected to affect one or more of the
endophenotypes; 92 genes from the Consortium on the Genetics of
Schizophrenia (COGS) that have received considerable support
as relevant to schizophrenia endophenotypes (Greenwood et al.,
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2013), some of which are in the set of endophenotypes we exam-
ined as well; and endophenotype-specific genes that were different
for each endophenotype. Only two findings emerged as significant,
GABRA1 for delta power and GRIK3 for overall startle. GABRA1
encodes for a GABA receptor and has been associated with alcohol
misuse (Dick et al., 2006). However, it has not been previously
linked to delta power and, in MTFS analyses, it was not associated
with alcohol use or misuse (Irons et al., 2014; McGue et al., 2013;
Vrieze et al., 2013). GRIK3, one of the COGS genes selected for its
relevance to schizophrenia, is involved in the glutamate system. It
has not previously been associated with startle. In the exome chip
paper, the endophenotype-general candidate genes were also evalu-
ated for the influence of rare variant effects if they possessed
sufficient nonsynonymous variation. None of the gene-based tests
was significant.
Although GABRA2 is listed in the table, this entry is bracketed
because the result did not exceed the Bonferroni threshold for
significance (α = 3.12 × 10−3). We list it, however, because,
among the endophenotype-specific candidate genes we examined
for EEG measures, the relationship between GABRA2 and EEG
beta power has, compared to the other endophenotype-specific
effects examined, perhaps the strongest track record as a repli-
cated effect. Given that, had we examined only this one possible
association, we would have been delighted to report our finding,
with a p value of .014, as corroboration of prior reports. But in
the context of the many tests we carried out and the assumption
implicit in Bonferroni correction that all hypotheses are equally
plausible, it is not significant. This indicates the dilemma every
scientist faces when deciding how to separate wheat from chaff in
molecular-genetic research.
To summarize, almost all of our endophenotypes showed mod-
erate to strong biometric heritability determined at least in part by
the combined effect of hundreds of thousands of SNPs. However,
using a wide array of molecular-genetic analytic approaches, no
solid leads were identified when examining individual genes or
SNPs; these remain very much unknown. The genetics of our
endophenotypes are thus like that of other complex traits, including
psychiatric disorders. They are not simple and therefore not likely
to lead to the identification of important risk alleles for psychiatric
disorders.
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Figure 1. Summary of heritability results from biometric analyses and genome-wide complex trait analyses (GCTA) for each endophenotype. The x axis
indicates the psychophysiological variable, while the y axis shows the percentage of variance accounted for. “Biometric A” (black bars) denotes the estimate
of the additive genetic component obtained in conventional family-based biometric models of each endophenotype. “GCTA Family” (light gray bars) represents
GCTA estimates of endophenotypic variance accounted for by the combined effect of all 527,829 single nucleotide polymorphisms (SNPs) used in GWAS
analyses with all MTFS participants included. This GCTA model accounts for the effect of all causal variants, including nonadditive genetic effects, but the
estimate provided removes the effect contributed by shared environmental influence. “GCTA Median” (dark gray bars) represents the average GCTA value for
each endophenotype based on the GCTA estimates for unrelated people. It indicates the additive heritability conferred by all the SNPs on the genotyping array
using two different GCTA models (based on unweighted SNPs or weighting SNPs by local linkage disequilibrium patterns) and three different subsamples of
unrelated participants (using genetic relatedness matrix values of .025, .05, and .10). The P3 genetic factor score is not included in the figure because it represents
only genetic variance, i.e., has a biometric heritability of 100%. Total power is equal to the sum of theta, delta, beta, and CZ alpha power.
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Unknown Unknowns: Strategies for Exploration
What are the potential reasons for our lack of significant findings?
The Perspective and Commentary pieces raise a number of impor-
tant issues regarding challenges and limitations confronted in the
execution of these studies, and potential strategies to finding the
molecular-genetic bases of endophenotypes. Here, we respond to
key points that were raised.
Statistical Power
Several commentaries drew attention to ways in which power to
detect many more SNPs or genes could have been limited by
characteristics of the MTFS sample. The comments are instructive,
and provide useful examples of ways in which analytical strategy
and psychophysiological theory can lead to possibly improved
study design for the detection of genetic associations with
endophenotypes.
Underrepresentation of pathological extremes. Ours is a
general population sample, so extreme pathology (like schizophre-
nia or autism) is not represented to any significant extent. Hence, as
Cuthbert (2014, this issue) points out, it is possible that we would
have more promising results had we overselected for cases at the
extremes. We agree, but it is nonetheless the case that common
mental disorders are amply represented in the MTFS, with rates
suggesting that a thousand or more individuals in these endo-
phenotype studies are affected with disorders like depression and
alcoholism. Examining lifetime prevalence of selected disorders in
MTFS older cohort twins based on in-person structured psychiatric
interviews, Hamdi and Iacono (2014) reported the following
rates: antisocial personality disorder (7.7%), cannabis dependence
(9.9%), alcohol dependence (21.2%), major depression (27.0%),
and nicotine dependence (32.8%). The age-11 prevalence of
ADHD among younger-cohort and ES twins is 7% (Keyes et al.,
2009). The parents of the twins also show high lifetime rates
(20–22%) of alcohol dependence and illicit drug abuse or depend-
ence (Holdcraft & Iacono, 2002, 2004). Other MTFS reports also
document significant rates of offspring and parent internalizing and
externalizing disorders (Hicks, DiRago, Iacono, & McGue, 2009;
Marmorstein, Iacono, & McGue, 2009; Wilson, Vaidyanathan,
Miller, McGue, & Iacono, in press). While it is possible that more
extreme cases would have helped boost our yield of hits, our results
cannot be attributed to our having studied only mentally healthy
individuals.
Sample too small. One presumed advantage of neurobiologically
informed endophenotypes is that their associated genetic effect
sizes should be larger than they are for their more complex and
distal but related clinical phenotypes. We had 80% power to detect
effects accounting for 1.4% of the variance in P3 amplitude, as one
example. When we began this molecular-genetic project in 2007,
we were thus optimistic that our large sample would prove
adequate for the purpose. Our results indicate that a much larger
sample would be needed. While it would of course be desirable to
substantially increase sample size, it is important to consider how
large would be large enough given the cost, time, and effort to
collect this type of laboratory data. For P3 amplitude, which has
strong support as an endophenotype for substance use and related
child and adult externalizing disorders (which, as noted above, are
well represented in the MTFS), our largest effect accounted for
.33% of the variance. We would need 20,000 individuals to have
sufficient power to detect an effect of this magnitude. Even with
such a large sample, that would likely be the only effect we would
have the power to detect because most effects can be expected to be
considerably smaller in magnitude. If samples of tens of thousands
are required to unravel endophenotype genetics and considering, as
Baker (2014, this issue) points out, that their relevance to the
genetics of psychopathology would still need to be determined,
they are not likely to serve well their intended purpose of facilitat-
ing psychiatric disorder gene finding.
Sample developmentally heterogeneous. Our sample is ethni-
cally homogenous, but composed of distinctly different age groups
comprising middle-aged parents and age-17 offspring. Although
we adjusted for age, generation, and birth year to account for
possible age-related effects, as Baker noted (2014, this issue),
it is possible that the genes contributing to variation in our endo-
phenotypes are different at various points in development, a factor
that could weaken our ability to detect an effect. Multivariate,
longitudinal approaches can assess genetic contributions to “inno-
vations,” or new sources of variance in a longitudinal context, as
well as genetic contributions that are relatively constant. They can
also be sensitive to gene-environment interactions (Kaprio, 2012).
Indeed, in other work in the MTFS sample, we have shown that
genetic variants associated with height and smoking in adulthood
show smaller effects for those respective measures during adoles-
cence, and we look forward to future work evaluating similar
hypotheses for endophenotypes. For the moment, however, we
caution that we are not aware of studies that show developmentally
heterogeneous genetic effects for our chosen endophenotypes at the
ages we examined. For the one endophenotype that we have
studied developmentally, P3 amplitude, the evidence suggests that
the same genetic influences span adolescence to young adulthood
(from age 17 to 24; Carlson & Iacono, 2006).
Choice of p-Value Thresholds for Significance
It is possible that our p-value cutoffs are either too stringent or two
liberal. There is no easily achieved consensus regarding how to set
these thresholds. Across all the empirical papers, we carried out in
excess of 500 million statistical tests, expecting over 25 million to
be significant at p < .05. Had we not published these papers as a
set following prescribed procedures standardizing the analytic
approach across them, readers would not easily recognize the pre-
dicament created by advancing a handful of “significant” findings
in the context of so many tests. Faced with this reality, we believe
we had little choice but to adopt conventional p-value cutoffs to
control the familywise error rate on a per-phenotype basis, and to
be cautious in the interpretation of our results. However, the thresh-
olds we adopted in this special issue still come with the obvious
cost incurred by the many false negatives buried in our data.
Schumann (2014, this issue) and Patrick (2014, this issue) both
made valuable suggestions regarding how to move beyond the
impasse created by the burden of correcting for multiple tests, and
we agree with the majority of our commentators that multi-
investigator consortia built from pooled, harmonized data collected
across many laboratories is one way to overcome this problem.
Possible Contribution of Nonadditive Effects
We are not measuring potentially important nonadditive effects,
such as dominance and recessive single-locus effects. However,
research on complex traits in humans has provided scant evidence
that such effects are overwhelmingly important or detectable even
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with massive sample sizes. Had we adjusted our models to test for
them, we would have added even more to the already high multiple
testing burden. In response to the concern that we might be missing
dominance effects, as a follow-up to our GCTA analyses, we
reanalyzed the endophenotypes using a variant of the GCTA
model recommended for family data (Yang, Lee, Goddard, &
Visscher, 2013) in which we modeled, and thus statistically con-
trolled, dominance effects (as well as shared environmental influ-
ences) from family relationships while estimating the magnitude of
shared genetic influences. For the 17 endophenotypes, dominance
accounted for 0 to 13% of the variance (median .05), producing
95% confidence intervals that did not overlap zero (and thus indi-
cated significant dominance effects) for eight of the measures
(antisaccade error [7%], skin conductance level [10%], and
response frequency [7%], and several EEG measures: occipital-
parietal alpha power [5%], beta [4%], theta [10%], delta [13%], and
total power [5%]). These results, which were largely nonsignificant
or produced small effects, indicate that our molecular-genetic find-
ings were unlikely to be substantially affected by our focus on the
additive effects of SNPs.
As Goldman (2014, this issue) notes, epistasis, which is key to
the type of emergenic traits and network interactions that Miller
et al. (Miller, Clayson, & Yee, 2014, this issue) and Schumann
(2014, this issue) discussed, is another possible contributing
factor we did not evaluate. In our experience, epistasis is only
evaluated once a number of known genetic loci have been iden-
tified, and then pairwise tests of epistasis are conducted on those
known loci. This is due to the overwhelming multiple testing
burden incurred by naively testing all pairwise SNP combina-
tions. For instance, if we confined ourselves to examine just
pairwise interactions for the SNPs we evaluated in our GWAS
analyses, we would need to adopt a p-value cutoff of 5 × 10−16. If
we included the 27 million variants from the sequencing study,
we would need to calculate hundreds of trillions of statistical
tests! Methods are being developed to prioritize SNPs for explor-
ing interaction effects using statistical learning algorithms
(Lubke et al., 2013). Nevertheless, the computational burden is
significant, and accommodating the family structure of our
sample may not always be simple. Although some nonadditive
effects may be important, additive effects comprise the most
obvious initial candidate to explore, which we have done
comprehensively.
Refine the Endophenotype
Some commentaries raised concerns about how the endophe-
notypes were operationally defined, measured, and analyzed. As
Baker (2014, this issue) noted, our endophenotypes could be prof-
itably recast, using multivariate modeling, in a way that facilitates
identifying shared genetic influences across measures and pheno-
types, possibly including DSM clinical phenotypes. Bivariate
analyses of endophenotype and associated trait or disorder provide
an opportunity to converge on the genetic overlap between the two,
which is certain to be small in magnitude. Focusing on P3 ampli-
tude, Ford (2014, this issue) presented a wealth of creative ideas
intended to improve the genetic yield by enhancing reliability and
heritability as well as parsing P3 amplitude into components that
may prove more genetically tractable (providing “endophenotypes
for endophenotypes”; see Miller & Rockstroh, 2013). These are
worthy goals, and their implementation could lead to the identifi-
cation of some associated SNPs, perhaps uncovering important
genetic clues that were missed.
However, we are doubtful that implementation of these ideas
would dramatically change the genetic landscape for P3 or our
conclusions about its genetic architecture. High heritability is not a
requirement, nor does it portend success, for finding SNPs or rare
variants. The multivariate P3 genetic factor score we examined has
a heritability of 1.0 yet produced results that varied indistinguish-
ably from those associated with P3 amplitude. Moreover, heritabil-
ity varied across the set of endophenotypes from exceptionally high
(∼.85) to zero, yet the likelihood of obtaining significant molecular-
genetic results clearly did not depend on endophenotype heritabil-
ity; approximately 30% of the filled cells in Table 1 are for affective
modulated startle indices, which are the least heritable of our meas-
ures. Nor did the likelihood of obtaining a significant “hit” depend
on the apparent complexity of the endophenotype; those with the
simplest neural circuitry, such as electrodermal orienting and eye
blink startle, were no more likely to produce an association than the
more complex ones.
Our analysis of P3 endophenotype-specific candidate genes,
which produced null results for P3 recorded at parietal leads,
included genes identified in prior GWAS using an oddball event-
related potential protocol (Kang et al., 2012; Zlojutro et al., 2011).
However, the identified genes were associated with a time-
frequency component of frontal theta power associated with the
P3 event-related potential. Had we included this same measure,
perhaps we would have affirmed these results. However, using
MTFS samples, we found that the time-frequency constituent com-
ponents of P3 are strongly correlated with the time-domain P3
amplitude measure we used (Gilmore, Malone, Bernat, & Iacono,
2010; Gilmore, Malone, & Iacono, 2010; Yoon, Malone, Burwell,
Bernat, & Iacono, 2013). Moreover, in MTFS twins, P3 and its
time-frequency components show stronger association with the
clinical phenotypes in the externalizing spectrum when measured
at parietal as opposed to frontal sites (Yoon et al., 2013). Thus,
considering the consistency in our findings across many measures,
it becomes difficult to resist the notion that, to borrow from Ger-
trude Stein, there is not much “there there,” and thus little reason to
expect further refinement of the endophenotype to lead to valid
genetic associations.
To summarize, our commentators have made a number of valu-
able suggestions that represent possible reasons for our lack of
significant findings and strategies to implement in the future that
may yield discoveries. It is worth noting that our knowledge of
psychiatric genetics remains very much in its infancy—very much
a world of “unknown unknowns.” Thus, as Patrick (2014, this
issue) points out, publication of both positive and negative findings
(i.e., considering all available information) is required before con-
clusions of any sort are warranted.
Looking to the Future
In addition to the suggestions made by the commentators, such as
increasing sample size through meta-analysis, several steps can be
taken to further genetic association studies of endophenotypes.
Prioritize Sets of Genetic Variants of Known/Predicted
Function that Are Enriched for Association
Our analytic strategy encompassed two naïve extremes, one repre-
sented by tests of each individual SNP in isolation and the other by
a single GCTA test of all in aggregate. The genome-wide scan
might be improved upon by differentially weighting groups of
SNPs (Roeder, Devlin, & Wasserman, 2007), such as those
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expressed in brain versus those not, or those implicated by prior
research. Examining multiple markers, rather than one SNP at a
time, is another possibility, which can provide increased power
(Pan, 2008) and which also permits pathway or network analysis.
Such methods incorporate prior biological knowledge or informa-
tion about the topological relationship among genes in a network.
This might be valuable for assessing matrix-based endophenotypes
(Schumann, 2014, this issue). These methods also provide a means
to evaluate gene-gene interactions while constraining the search
space. It is now possible to focus on those genetic variants known
to influence gene expression (so-called expression quantitative trait
loci, or eQTLs), rather than examine all SNPs. Massive publicly
available datasets now provide comprehensive maps of enhancers,
insulators, promoters, and eQTLs, all part of the genetic regulatory
system that controls gene expression levels. Chromatin state infor-
mation can be used to prioritize SNPs with genomic function
(Pickrell, 2014). Whole-genome sequences are especially valuable
for these tests, as they provide exhaustive directly genotyped vari-
ants within functional regions instead of relying on tag SNPs and
common variants. In fact, we are currently pursuing such analyses
ourselves. When a significantly associated variant is eventually
found and replicated, these functional categories can prove valu-
able in understanding how that variant influences the genome to
affect the trait of interest.
Expand Genetic Diversity
Individuals of European ancestry, such as those making up our
sample, possess only a small fraction of the total genetic variation
in the human population (1000 Genomes Project Consortium,
2012); Africa alone has more genetic diversity than the rest of the
world combined. There are myriad examples of genetic effects that
are largely limited to specific ancestral or founder populations, and
the absence of a significant finding in a European sample does not
preclude the discovery of a large-effect variant identified in a dif-
ferent ancestral group. This is especially true for rare variants,
where ancestral divergence is the rule.
Extend Sequencing Analysis
One major hurdle in rare variant association analysis is statistical
power—rare variants may have very large effects but still account
for tiny fractions of population disease burden. For example, recent
research has identified rare variants affecting macular degeneration
with odds ratios of 20:1 (Raychaudhuri et al., 2011) and similarly
large effects on other diseases (Cohen & Hobbs, 2013; Sigma Type
2 Diabetes Consortium et al., 2014; TG and HDL Working Group
of the Exome Sequencing Project, 2014). However, even a com-
pletely penetrant rare variant can only account for a tiny fraction of
disease burden, because it affects so few people. Cardiovascular
disease causes over half a million deaths annually, but a rare variant
present in only 1 in 10,000 individuals can only be responsible for
50 of those deaths. For analogous reasons, any individual rare
variant cannot account for substantial heritability in any given
population, even with a huge effect size (yet another way that
heritabilities are unreliable guides in the discovery of gene
associations).
Achieving sufficient power to detect rare variant effects (even
large ones) is an important consideration in the design of future
studies, of endophenotypes or otherwise. Rare variants of known
function, such as a protein-truncating stop-gain variant, or an
insertion-deletion that displaces a motif within a strong enhancer,
can provide directional and biologically plausible tests of associa-
tion. As Goldman (2014, this issue) suggests, detailed and system-
atic study of functional rare variants, with follow-up of promising
signals in carrier family members, is a way to efficiently obtain
many copies of an otherwise rare variant (e.g., see Bevilacqua
et al., 2010). Indeed, the longitudinal MTFS cohorts are ideally
suited to recruit additional family members in order to replicate
promising findings concerning rare variants. The sequencing analy-
ses reported in this special issue only scratched the surface of
possibility, and we are already actively expanding that analysis in
many ways.
Conclusions: Limits of the Knowns and Unknowns
These MTFS papers represent the first comprehensive effort to
examine the possible etiologic relevance of common and rare
genetic polymorphisms for a wide range of psychophysio-
logical endophenotypes using genome-wide and candidate-
targeted methods applied to the largest sample employed for
such a purpose to date. We make no claim that it is appropriate to
generalize our conclusions to every possible variable that could be
considered an endophenotype. However, given our results and the
current state of the literature on psychiatric endophenotypes, in the
absence of contrary evidence, we believe it is fair to apply our
conclusions broadly. It is also worth noting that the variables we
tested ranged in neurobiological complexity from being generated
by networks of brain structures (e.g., EEG power spectra and P3) to
those presumed to have simple underlying circuitry (e.g., startle).
Regardless of the variable tested, our conclusions were largely the
same. Considering our results across the seven empirical papers in
this special issue, we offer the following conclusions.
Our Findings Warrant Further Investigation
As Table 1 highlights, we do have significant findings. While many
could be false positives, they nevertheless emerged against the
backdrop of a carefully considered and conservative data analytic
approach, thus warranting attention in future investigations. To our
knowledge, this work provides the first examination of the possible
contribution of rare variants to endophenotype genetics using
exome chip and whole-genome sequencing methods. The results
suggest that these approaches, like GWAS based on common vari-
ants, are also worth pursuing with psychophysiological measures.
As Wilhelmsen (2014, this issue) noted, findings based on small
effects may have important biological significance and rare variants
can readily implicate genomic regions and etiological mecha-
nisms, with especially profound consequences for the families that
carry them. As can be seen from our tabled data in the articles and
supporting information, we have many effects that, despite not
attaining statistical significance, are associated with quite small p
values. Almost certainly, some of these are true associations. It will
be up to future investigators to coax the signal out of the data by
showing that their effects can be corroborated by ours.
Endophenotypes Are Massively Polygenic
Our findings suggest that, like other complex traits,
endophenotypes are polygenic, reflecting the contribution of a very
large number of genetic variants each contributing very small
effects.
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Endophenotypes Likely Reflect the Influence
of Rare Variants
Polygenic inheritance does not preclude the possibility, perhaps
strong, of rare variants with large effects. Such variants can only
account for a tiny fraction of heritability in a population for the
simple reason that they affect only a very small number of individ-
uals. While we tested rare variants in the present work and found a
few potential signals, this work was conducted with approximately
one third the whole sample. Falling costs will permit studying
larger samples, and additional studies in carefully selected samples
will be required to further evaluate the contribution of rare variants
in these endophenotypes.
Endophenotypes Will Not Simplify Gene-Finding for
Psychiatric Disorder
The promise of endophenotypes has been oversold. Even if
endophenotypes are conceptually simpler than DSM (Diagnostic
and Statistical Manual of Mental Disorders) diagnoses and closer
to underlying biology, endophenotype genetics are not sufficiently
simpler genetically to aid in gene discovery in a sample the size of
MTFS. Consequently, the same challenges that make psychiatric
genetics difficult are likely to make endophenotype genetics
difficult.
Endophenotype Genetics Might Contribute Important
Biologic Insights for Psychiatric Disorders
As de Geus (2010; 2014, this issue) and Munafò and Flint (2014,
this issue) have noted, the value of endophenotypes may best be
realized after genetic variants for a disorder, trait, or biological
process are identified through other means such as large-sample
meta-analyses of relevant traits and work with model organisms.
Once genetic variants for clinical phenotypes are identified, we can
determine their relevance to specific endophenotypes, in turn gen-
erating insights into neural and psychological processes important
to clinical pathology. A related benefit of this approach will be
better understanding the neurobiology of endophenotypes and the
workings of endophenotype-relevant brain systems.
Next Steps
A theme echoed repeatedly throughout the special issue articles and
commentaries is the advantage of forming consortia to enhance
sample size such that the small effects of the genetic signals buried
in genetic noise can be identified without ballooning the rate of
false positives that comes by relaxing p values. For laboratory
measures, amassing large samples is challenging even when
pooling across laboratories. However, consortia like ENIGMA
(Enhancing Neuro Imaging through Meta-Analysis; http://
enigma.ini.usc.edu/), which includes an EEG offshoot, indicate
that success is possible. In addition, it should be possible to develop
methods that facilitate large-scale data collection outside the
laboratory using inexpensive monitors, such as physiological rec-
ording devices already in popular use by fitness enthusiasts.
Smartphones permit recording photoplethysmographic data, while
mobile EEG recording devices are proliferating. Brain-computer
interfaces and other technologies to assist individuals with disabil-
ities may provide useful tools for “crowd-sourcing” data collection
as well.
Our results suggest that the focus of endophenotypic theory and
research should change, moving away from gene finding to using
the results of gene finding to understand psychophysiological
mechanisms of etiological relevance to psychopathology. As
Braff (2014, this issue) notes in his commentary, the value of these
MTFS endophenotype papers may best be realized in what comes
next with projects that combine the study of molecular genetics,
endophenotypes, and psychiatric disorder, such as COGS. As we
and others continue to expand our work, we must actively seek to
share data readily, rapidly, and unconditionally with other research-
ers, preferably without embargo. Open science and open consents
may not always be practical or appropriate but should be pursued to
the fullest extent possible. It is our hope that this special issue
provides a foundation for such cooperation, informing future steps
in endophenotype genetics that enable a more satisfying answer
than Mr. Rumsfeld’s about what is known and what is not.
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